ProfoundBio, based in Woodinville, Wash., and Suzhou, China, has raised $55 million in a Series A funding round to advance its programs developing new anti-cancer agents. The company is led …
( read original story …)
The Shanghai News
ProfoundBio, based in Woodinville, Wash., and Suzhou, China, has raised $55 million in a Series A funding round to advance its programs developing new anti-cancer agents. The company is led …
( read original story …)